Thomas Meyer founded Auris Medical in April 2003 and was the Company's sole shareholder until the end of 2007. Prior to founding Auris Medical, he was the Chief Executive Officer of Disetronic Group, a leading Swiss supplier of precision infusion and injection systems. He worked for Disetronic in various functions starting in 1988, becoming member of the Board of Directors in 1996, Deputy Chief Executive Officer in 1999 and Chief Executive Officer in early 2000. Prior to joining Disetronic, he advised several Swiss companies in strategy, marketing and corporate finance. Thomas Meyer served on the Board of Directors of several small and medium sized Swiss industrial companies; in some of them he was also a key investor. He holds a Ph.D. in business administration (Dr.rer.pol.) from the University of Fribourg, Switzerland.
Elmar Schaerli, CPA, has served as Auris Medical’s Chief Financial Officer since November 2019. Mr. Schaerli has aquired almost 30 years of both private and public finance and accounting experience in the biotech and medtech industry. In 2003 he founded ante treuhand ag, a Swiss fiduciary company supporting companies primarly in health care and technology, and has since served as its CEO.
Raoul Dias has served as Auris Medical’s General Counsel & Secretary since July 2018 and as Senior Counsel & Secretary since November 2017. Prior to joining Auris Medical, he had worked as Senior Counsel at